Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001178913-20-002949
Filing Date
2020-10-30
Accepted
2020-10-30 16:30:32
Documents
25
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 6-K/A zk2025056.htm 6-K/A 14158
2 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 677170
  Complete submission text file 0001178913-20-002949.txt   1683137

Data Files

Seq Description Document Type Size
3 XBRL INSTANCE DOCUMENT mdwd-20200630.xml EX-101.INS 142180
4 XBRL TAXONOMY EXTENSION SCHEMA mdwd-20200630.xsd EX-101.SCH 19696
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mdwd-20200630_cal.xml EX-101.CAL 45936
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mdwd-20200630_def.xml EX-101.DEF 36919
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdwd-20200630_lab.xml EX-101.LAB 174660
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdwd-20200630_pre.xml EX-101.PRE 109304
Mailing Address 42 HAYARKON STREET YAVNE L3 8122745
Business Address 42 HAYARKON STREET YAVNE L3 8122745 97289324010
MediWound Ltd. (Filer) CIK: 0001593984 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K/A | Act: 34 | File No.: 001-36349 | Film No.: 201277743
SIC: 2833 Medicinal Chemicals & Botanical Products